NEW YORK (GenomeWeb News) - Molecular Devices’ shares surged 47 percent in afternoon trading to $35.05 from Friday’s close of $23.38, in the wake of this morning’s announcement that the company will be bought by MDS.
 
MDS said earlier today that it will pay $615 million in cash for Molecular Devices and combine the firm with its MDS Sciex business.
 
MDS’ stock was up 1.17 percent to $17.30.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.